Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments
RecruitingNCT07404761Phase: NAStarted 2025-12-22
Summary
This is a multicenter, randomized, controlled clinical study evaluating the safety and effectiveness of the Spatial StimelMD (SSMD) device for upper-limb neuromotor rehabilitation in adults with impai
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Bnai Zion Medical CenterHaifa, Israel
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07404761